Lauren DiPetrillo

711 total citations
23 papers, 517 citations indexed

About

Lauren DiPetrillo is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Lauren DiPetrillo has authored 23 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 3 papers in Physiology. Recurrent topics in Lauren DiPetrillo's work include Schizophrenia research and treatment (19 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (8 papers). Lauren DiPetrillo is often cited by papers focused on Schizophrenia research and treatment (19 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (8 papers). Lauren DiPetrillo collaborates with scholars based in United States, Ireland and Germany. Lauren DiPetrillo's co-authors include Bernard L. Silverman, Ying Jiang, Elliot Ehrich, Christoph U. Correll, David McDonnell, Adam Simmons, Yangchun Du, Aslı Memişoğlu, William Martin and Christine Graham and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Lauren DiPetrillo

21 papers receiving 497 citations

Peers

Countries citing papers authored by Lauren DiPetrillo

Since Specialization

Citations

This map shows the geographic impact of Lauren DiPetrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren DiPetrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren DiPetrillo more than expected).

Fields of papers citing papers by Lauren DiPetrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren DiPetrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren DiPetrillo. The network helps show where Lauren DiPetrillo may publish in the future.

Co-authorship network of co-authors of Lauren DiPetrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren DiPetrillo. A scholar is included among the top collaborators of Lauren DiPetrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren DiPetrillo. Lauren DiPetrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study 2022 ·Schizophrenia Bulletin ·Christoph U. Correll, Evan A. Stein, Christine Graham, Lauren DiPetrillo, Sarah Akerman, Arielle D. Stanford, Ying Jiang, (unknown), David McDonnell, (unknown)	17
2	An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder 2021 ·Neuropsychiatric Disease and Treatment ·Leslie Citrome, Christine Graham, Adam Simmons, Ying Jiang, Mark S. Todtenkopf, Bernard L. Silverman, Lauren DiPetrillo, (unknown), Lei Sun, David McDonnell	17
3	A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension 2021 ·Schizophrenia Research ·René S. Kahn, Bernard L. Silverman, Lauren DiPetrillo, Christine Graham, Ying Jiang, Jiani C. Yin, Adam Simmons, (unknown), Bei Yu, (unknown), (unknown), David McDonnell	33
4	Long-Term Weight and Metabolic Effects of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies 2021 ·Biological Psychiatry ·John W. Newcomer, Ying Jiang, Lauren DiPetrillo, (unknown), Bei Yu, (unknown), David McDonnell, Christine Graham	1
5	Reduced Risk Across Multiple Cardiometabolic Risk Factors With OLZ/SAM Compared With Olanzapine: Results From a 24-Week Phase 3 Study 2021 ·Biological Psychiatry ·Christoph U. Correll, Evan A. Stein, Christine Graham, Lauren DiPetrillo, Sarah Akerman, Arielle D. Stanford, Ying Jiang, (unknown), David McDonnell, (unknown)	1
6	Phase 3 Safety and Tolerability Results of the Combination Olanzapine and Samidorphan in Patients with Schizophrenia: The 1 Year ENLIGHTEN-2-Extension 2021 ·CNS Spectrums ·René S. Kahn, Bernard L. Silverman, Lauren DiPetrillo, Christine Graham, Ying Jiang, Jiani C. Yin, Adam Simmons, (unknown), Bei Yu, (unknown), (unknown)	2
7	Long-Term Antipsychotic Efficacy of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies 2021 ·Biological Psychiatry ·René S. Kahn, Christine Graham, Ying Jiang, Lauren DiPetrillo, (unknown), (unknown), David McDonnell	1
8	Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia 2020 ·The Journal of Clinical Psychiatry ·Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, Adam Simmons, Ying Jiang, Lauren DiPetrillo, David McDonnell	47
9	Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder 2020 ·The Journal of Clinical Psychiatry ·Mary F. Brunette, Christoph U. Correll, (unknown), David McDonnell, Lauren DiPetrillo, Ying Jiang, Adam Simmons, Bernard L. Silverman, Leslie Citrome, Alan I. Green	18
10	Course of Psychosis in Schizophrenia With Alcohol Use Disorder 2020 ·The Journal of Clinical Psychiatry ·Sanjeev Pathak, Ying Jiang, Lauren DiPetrillo, Mark S. Todtenkopf, Yan Liu, Christoph U. Correll	3
11	100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study 2020 ·CNS Spectrums ·Christoph U. Correll, John W. Newcomer, Bernard L. Silverman, Lauren DiPetrillo, Christine Graham, Ying Jiang, Yangchun Du, Adam Simmons, (unknown), David McDonnell, René S. Kahn	0
12	Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia 2019 ·American Journal of Psychiatry ·William Martin, Christoph U. Correll, Peter J. Weiden, Ying Jiang, Sanjeev Pathak, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich	67
13	Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study. 2019 ·PubMed ·Leslie Citrome, Stephanie S. O’Malley, David McDonnell, Ying Jiang, Adam Simmons, (unknown), Lauren DiPetrillo	4
14	Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study 2018 ·The Journal of Clinical Pharmacology ·Sanjeev Pathak, Bradley Vince, Debra Kelsh, Beatrice Setnik, Narinder Nangia, Lauren DiPetrillo, Matthew D. Puhl, Lei Sun, Arielle D. Stanford, Elliot Ehrich	11
15	F232. A PHASE 3 STUDY TO DETERMINE THE ANTIPSYCHOTIC EFFICACY AND SAFETY OF ALKS 3831 IN ADULT PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA 2018 ·Schizophrenia Bulletin ·David McDonnell, Steven G. Potkin, Adam Simmons, Ying Jiang, Lauren DiPetrillo, Bernard L. Silverman	1
16	A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers 2017 ·Schizophrenia Research ·Bernard L. Silverman, William Martin, Aslı Memişoğlu, Lauren DiPetrillo, Christoph U. Correll, John M. Kane	42
17	76. Alks 5461: A Buprenorphine-Samidorphan Combination for Major Depression 2017 ·Biological Psychiatry ·Elliot Ehrich, Sanjeev Pathak, William Martin, (unknown), Arielle D. Stanford, Lauren DiPetrillo	1
18	Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial 2016 ·American Journal of Psychiatry ·Maurizio Fava, Aslı Memişoğlu, Michael E. Thase, J. Alexander Bodkin, Madhukar H. Trivedi, (unknown), Yangchun Du, Richard Leigh-Pemberton, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich	134
19	Single- and Multiple-dose Pharmacokinetics of Samidorphan, A Novel Opioid Antagonist, in Healthy Volunteers 2014 ·Clinical Therapeutics ·Ryan Z. Turncliff, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich	32
20	ALKS 37, A Novel, Peripherally-Restricted Opioid Receptor Antagonist, Demonstrates Efficacy in the Treatment of Opioid-Induced Bowel Dysfunction. 2011 ·Gastroenterology ·Lauren DiPetrillo, Richard Leigh-Pemberton, Aslı Memişoğlu, Ryan Z. Turncliff, (unknown), Bernard L. Silverman, Elliot Ehrich	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact